Skip to main content
Have a personal or library account? Click to login
Epidermal Growth Factor Receptor immunohistochemical expression in hepatocellular carcinoma without Epidermal Growth Factor Receptor exons 18–21 mutations Cover

Epidermal Growth Factor Receptor immunohistochemical expression in hepatocellular carcinoma without Epidermal Growth Factor Receptor exons 18–21 mutations

Romanian Journal of Internal Medicine
Volume 60 (2022): Issue 3 (September 2022)
By: ,  ,  ,  ,   and    
Open Access
|Sep 2022
Metrics

Metrics

DOI: https://doi.org/10.2478/rjim-2022-0006 | Journal eISSN: 2501-062X | Journal ISSN: 1220-4749
Journal RSS Feed
Language: English
Page range: 153 - 159
Submitted on: Feb 26, 2022
Published on: Sep 22, 2022
Published by: N.G. Lupu Internal Medicine Foundation
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Epidermal Growth Factor Receptor,
hepatocellular carcinoma,
survival,
gene mutation,
exon 18–21,
immunohistochemistry,
hepatitis B virus infection
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Internal medicine, other,
Cardiology,
Gastroenterology,
Rheumatology

© 2022 Dafina Nikolova, Meri Trajkovska, Emilija Nikolovska Trpcevska, Aleksandar Eftimov, Rubens Jovanovik, Vesna Janevska, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 60 (2022): Issue 3 (September 2022)
Previous article
Next article